Barclays’s Strata Critical Medical Inc SRTA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$441K	Sell	105,472 -93,300	-47%	-$449K	﹤0.01%	3264
2025 Q4	$956K	Buy	198,772 +15,018	+8%	+$72.6K	﹤0.01%	3459
2025 Q3	$930K	Sell	183,754 -15,704	-8%	-$69.4K	﹤0.01%	3412
2025 Q2	$804K	Buy	199,458 +47,981	+32%	+$156K	﹤0.01%	3482
2025 Q1	$414K	Sell	151,477 -28,114	-16%	-$101K	﹤0.01%	3637
2024 Q4	$763K	Buy	179,591 +13,437	+8%	+$51.2K	﹤0.01%	3559
2024 Q3	$488K	Buy	166,154 +56,079	+51%	+$178K	﹤0.01%	3789
2024 Q2	$383K	Sell	110,075 -40,651	-27%	-$136K	﹤0.01%	3208
2024 Q1	$430K	Sell	150,726 -40,449	-21%	-$125K	﹤0.01%	3684
2023 Q4	$675K	Buy	191,175 +54,864	+40%	+$157K	﹤0.01%	3698
2023 Q3	$353K	Buy	136,311 +94,149	+223%	+$331K	﹤0.01%	2996
2023 Q2	$166K	Buy	42,162 +1,341	+3%	+$4.25K	﹤0.01%	3338
2023 Q1	$138K	Buy	40,821 +13,583	+50%	+$55.4K	﹤0.01%	4000
2022 Q4	$97.5K	Buy	27,238 +12,863	+89%	+$55K	﹤0.01%	4238
2022 Q3	$58K	Sell	14,375 -932	-6%	-$4.79K	﹤0.01%	3735
2022 Q2	$68K	Buy	15,307 +3,312	+28%	+$23.9K	﹤0.01%	3923
2022 Q1	$102K	Buy	+11,995	New	+$84.3K	﹤0.01%	3769